Clinical Trials on Papillary Carcinoma in Hong Kong

Total 637 results

The University of Hong Kong

Suspended

A Trial Comparing USG-HIFU vs AS in Management of Low-risk PTMC

Papillary Thyroid Microcarcinoma

Hong Kong
Humanity & Health Medical Group Limited

Recruiting

Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC

Hepatocellular Carcinoma

Hong Kong
The University of Hong Kong

Recruiting

3D-Printed Patient-Specific Surgical Plates Versus Conventional Surgical Plates in Jaw Reconstruction

Dentofacial Deformities | Mandibular Neoplasms | Maxillary Neoplasms

Hong Kong
Humanity & Health Medical Group Limited
Beijing 302 Hospital; Kindai University Faculty of Medicine

Terminated

Safety and Efficacy of Lenvatinib in Subjects With HCC Progression After First Line Treatment With Checkpoint Inhibitors

Hepatocellular Carcinoma

Hong Kong
The University of Hong Kong
Chinese University of Hong Kong

Completed

Three-Dimensional Printing of Patient-Specific Titanium Plates in Jaw Surgery: A Pilot Study (3DJP16)

Maxillofacial Injuries | Dentofacial Deformities | Mandibular Neoplasms | Maxillary Neoplasms

Hong Kong
The University of Hong Kong
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt...

Completed

Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPC

Nasopharyngeal Carcinoma | Metastatic Cancer | Recurrent Carcinoma | Non-keratinizing Carinoma

Hong Kong
The University of Hong Kong
Food and Health Bureau, Hong Kong Government

Active, not recruiting

Hong Kong Breast Cancer Study

Breast Cancer | Ductal Carcinoma In Situ

Hong Kong
The University of Hong Kong

Recruiting

Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine Learning

Oral Squamous Cell Carcinoma

Hong Kong
The University of Hong Kong

Completed

Plasma Biomarker in Predicting Response and Toxicity in HCC Patients Treated With Checkpoint Inhibitors With or Without SBRT

Hepatocellular Carcinoma Non-resectable | Stereotactic Body Radiotherapy

Hong Kong
The University of Hong Kong

Recruiting

SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Substudy: Interconnection of Arterial Tumor Feeders Through Tumor Sinusoid in HCC

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Balloon Assisted Transarterial Therapy for Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Terminated

Chemoembolization for Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong

Completed

Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC (PACOX)

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002) (BCT-100-002)

Hepatocellular Carcinoma | Neoplasm

Hong Kong
Chinese University of Hong Kong
Health and Medicine Research Fund

Recruiting

Laparoscopic Versus Open Major Hepatectomy for HCC Hepatectomy for Hepatocellular Carcinoma (AP-LAPO)

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong
The Hong Kong Society of Gastroenterology

Completed

Cytokine Change in Hepatocellular Carcinoma Treated by Thermal Ablation

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver Cancer

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Study of Pegylated Human Recombinant Arginase for Liver Cancer

Hepatocellular Carcinoma | Neoplasm

Hong Kong
Chinese University of Hong Kong

Recruiting

The Microbiome of Oesophageal Squamous Cell Carcinoma

Esophageal Cancer | Microbial Colonization

Hong Kong
Chinese University of Hong Kong

Completed

Treatment for Bile Duct Cancer in the Liver

Cholangio Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Hepatocellular Carcinoma (HCC)_Torisel_

Inoperable HCC

Hong Kong
CCTU

Recruiting

Pembrolizumab in Hepatocellular Carcinoma

HCC

Hong Kong
The University of Hong Kong

Recruiting

TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma

HCC

Hong Kong
Chinese University of Hong Kong
Shenzhen Hospital of Southern Medical University; The Fifth Affiliated Hospital... and other collaborators

Recruiting

Hybrid APC for Gastric Low Grade Intraepithelial Neoplasia (HybridAPC)

Gastric Low Grade Intraepithelial Neoplasia

Hong Kong
Yung NA
Queen Mary Hospital, Hong Kong; Pamela Youde Nethersole Eastern Hospital

Recruiting

Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma: A Pilot Randomized Controlled Trial

Muscle-Invasive Bladder Carcinoma | Muscle Invasive Bladder Urothelial Carcinoma

Hong Kong
The University of Hong Kong
Queen Mary Hospital, Hong Kong

Recruiting

Tai-Chi and Aerobic Exercise to Improve Emotional Symptom Cluster in Late-stage Lung Cancer Patients

Advanced Lung Non-Small Cell Carcinoma

Hong Kong
Aegera Therapeutics
Chinese University of Hong Kong

Completed

XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)

Advanced Hepatocellular Carcinoma

China
The University of Hong Kong
Queen Mary Hospital, Hong Kong

Recruiting

Immunotherapy and Radioembolisation for Metastatic Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

TACE Emulsion Versus Suspension

Hepatocellular Carcinoma

Hong Kong
The University of Hong Kong

Completed

SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong
Prince of Wales Hospital, Shatin, Hong Kong

Completed

Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)

Hepatocellular Carcinoma

Hong Kong
The University of Hong Kong

Unknown

SBRT as Bridging Therapy for Hepatocellular Carcinoma Patients on Transplant Waitlist

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Dr Tan-to CHEUNG

Completed

Neoadjuvant Anti-PD1 in HCC

HCC | Hepatocellular Carcinoma | Liver Cancer

Hong Kong
Humanity & Health Medical Group Limited

Withdrawn

A Study to Evaluate Vaccines Against COVID-19 in the Real World

Chronic Liver Disease | Hepatic Carcinoma

Hong Kong
Chinese University of Hong Kong
Prince of Wales Hospital, Shatin, Hong Kong

Terminated

Combined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Terminated

A Study on the Angioarchitecture of Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Hong Kong
Chinese University of Hong Kong

Recruiting

Endoscopic Closure of Gastric ESD Defect

Gastric Dysplasia | Gastric Cancer in Situ

Hong Kong
Chinese University of Hong Kong

Recruiting

Fibroscan Study in HCC

Confirmed Diagnosis of Hepatocellular Carcinoma | Patients Who Are Scheduled to Undergo Transarterial Chemobolization, Systemic Therapy Surgery | Child's A to C Cirrhosis

Hong Kong
The University of Hong Kong

Completed

Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)

Carcinoma, Hepatocellular | Secondary

Hong Kong
Sanofi

Terminated

Docetaxel in Non Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

Hong Kong
Chinese University of Hong Kong

Completed

MK-2206 in Recurrent Nasopharyngeal Carcinoma (MC1079)

Recurrent Nasopharyngeal Carcinoma

Hong Kong
Lee's Pharmaceutical Limited

Recruiting

Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment

Advanced Hepatocellular Carcinoma

China
Chinese University of Hong Kong

Terminated

Ablative Chemoembolization for Unresectable and Large Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Hong Kong
Chinese University of Hong Kong

Completed

New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer

Advanced Nasopharyngeal Carcinoma

Hong Kong
The University of Hong Kong

Unknown

Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma (SECOX)

Advanced Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma

China
Chinese University of Hong Kong

Completed

Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation

Hepatocellular Carcinoma

China
Chinese University of Hong Kong

Completed

RCT on Adjuvant TACE After Hepatectomy for HCC (A-TECH)

Hepatocellular Carcinoma

China

Clinical Trials on Papillary Carcinoma in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations